Publications by authors named "Peter Carroll"

Claim this Profile
E
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare Data.
Kevin D Li, Marvin N Carlisle, Stephanie Jarosek, Hiren V Patel, Anna Faris, Peter R Carroll

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'.
Jesse K McKenney, James D Brooks, Jane K Nguyen, C K Cornelia Ding, Lisa F Newcomb, Peter R Carroll

Histopathology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer.
Kevin Shee, William A Pace, Andrew W Liu, Janet E Cowan, Vishvak Subramanyam, Peter R Carroll

Eur Urol Focus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer.
William S Chen, Abuzar Moradi Tuchayi, Ali Sabbagh, Inkyu Kim, Evan Porter, Peter R Carroll

JNCI Cancer Spectr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human level information extraction from clinical reports with finetuned language models.
Longchao Liu, Long Lian, Yiyan Hao, Aidan Pace, Elaine Kim, Peter R Carroll

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Comparison of Decipher 1.0 and 1.1 for Localized Prostate Cancer: Results in Prostatectomy and Active Surveillance Patients.
Brendan L Raizenne, Kevin Shee, Janet E Cowan, Peter R Carroll, Matthew R Cooperberg

Eur Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence.
Nancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, Deepika Sirohi, Matthew R Cooperberg, Peter R Carroll

Histopathology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study.
Meera R Chappidi, Lisa F Newcomb, Yingye Zheng, Menghan Liu, Jeannette M Schenk, Peter R Carroll

J Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivitamin Use After Prostate Cancer Diagnosis Is Associated with Lower Risk of Recurrence: A Prospective Cohort Study from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kevin Shee, Benjamin E Cedars, Lufan Wang, Stacey A Kenfield, Janet E Cowan, Peter R Carroll

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era.
Kevin Shee, Jonathan J Song, Janet E Cowan, Lufan Wang, James Nie, Peter R Carroll

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed definitive management of localized prostate cancer: what do we know?
Osama Mohamad, Yun Rose Li, Felix Feng, Julian C Hong, Anthony Wong, Peter Carroll

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time is on our side - rethinking the concept of time to treatment for prostate cancer.
Nynikka R Palmer, Peter R Carroll, Samuel L Washington

Nat Rev Urol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule RNA therapeutics to target prostate cancer.
Duygu Kuzuoglu-Ozturk, Hao G Nguyen, Lingru Xue, Emma Figueredo, Vishvak Subramanyam, Peter R Carroll

Cancer Cell· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort.
Kevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, Lufan Wang, William Pace, Peter R Carroll

Eur Urol Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry.
Chris Bangma, Paul Doan, Lin Zhu, Sebastiaan Remmers, Daan Nieboer, Peter Carroll

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium.
Yoichiro Tohi, John M Sahrmann, Jaron Arbet, Takuma Kato, Lui Shiong Lee, Peter Carroll

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.
Kevin Shee, James Nie, Janet E Cowan, Lufan Wang, Samuel L Washington, Peter R Carroll

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reevaluating the Definition of Clinically Significant Prostate Cancer as Grade Groups 2 to 5: An Imperative for Improved Risk Stratification.
Sigrid V Carlsson, Peter R Carroll, Freddie C Hamdy

J Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer.
Mary O Fakunle, Janet E Cowan, Samuel L Washington, Katsuto Shinohara, Hao G Nguyen, Peter R Carroll

J Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI.
Olga Starobinets, Jeffry P Simko, Matthew Gibbons, John Kurhanewicz, Peter R Carroll

Magn Reson Imaging· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
Jane K Nguyen, Lara R Harik, Eric A Klein, Jianbo Li, Dillon Corrigan, Peter R Carroll

Histopathology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.
Sagar A Patel, Dattatraya Patil, Joseph Smith, Christopher S Saigal, Mark S Litwin, Peter R Carroll

JAMA Netw Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Legends in Urology v31I05.
Peter R Carroll

Can J Urol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma.
Ryan Kohlbrenner, Xiao Wu, Hao G Nguyen, Matthew R Cooperberg, Tushar Chakravarty, Peter R Carroll

Radiology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
Farnoosh Nik-Ahd, Amanda M De Hoedt, Christi Butler, Jennifer T Anger, Peter R Carroll

JAMA· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis